"Occult Blood" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Chemical, spectroscopic, or microscopic detection of extremely small amounts of blood.
| Descriptor ID |
D009780
|
| MeSH Number(s) |
E01.370.225.925 E05.200.925
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Occult Blood".
Below are MeSH descriptors whose meaning is more specific than "Occult Blood".
This graph shows the total number of publications written about "Occult Blood" by people in this website by year, and whether "Occult Blood" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 0 | 1 | 1 |
| 2002 | 0 | 2 | 2 |
| 2003 | 3 | 0 | 3 |
| 2004 | 1 | 0 | 1 |
| 2005 | 1 | 0 | 1 |
| 2006 | 2 | 1 | 3 |
| 2007 | 0 | 2 | 2 |
| 2008 | 0 | 1 | 1 |
| 2009 | 1 | 0 | 1 |
| 2010 | 1 | 1 | 2 |
| 2011 | 0 | 2 | 2 |
| 2020 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Occult Blood" by people in Profiles.
-
Palma R, Pontone S, Marino IR, Magliocca FM, Frattaroli S, Tonini V, D'Andrea V. Sheep in Wolf's Clothing: Pedunculated Colonic Lipoma with Overlying Hyperplastic and Ulcerated Epithelium. Dig Dis Sci. 2020 07; 65(7):1951-1953.
-
Nash DB, Fabius RJ, Skoufalos A. Preventing Colorectal Cancer: Pathway to Achieving an 80% Screening Goal in the United States: Overview and Proceedings of a Population Health Advisory Board. Popul Health Manag. 2021 04; 24(2):286-295.
-
Hall MJ, Ruth K, Giri VN. Rates and predictors of colorectal cancer screening by race among motivated men participating in a Prostate Cancer Risk Assessment Program. Cancer. 2012 Jan 15; 118(2):478-84.
-
Tinmouth J, Ritvo P, McGregor SE, Claus D, Pasut G, Myers RE, Guglietti C, Paszat LF, Hilsden RJ, Rabeneck L. A qualitative evaluation of strategies to increase colorectal cancer screening uptake. Can Fam Physician. 2011 Jan; 57(1):e7-15.
-
Mosen DM, Feldstein AC, Perrin N, Rosales AG, Smith DH, Liles EG, Schneider JL, Lafata JE, Myers RE, Kositch M, Hickey T, Glasgow RE. Automated telephone calls improved completion of fecal occult blood testing. Med Care. 2010 Jul; 48(7):604-10.
-
Sifri R, Rosenthal M, Hyslop T, Andrel J, Wender R, Vernon SW, Cocroft J, Myers RE. Factors associated with colorectal cancer screening decision stage. Prev Med. 2010 Sep-Oct; 51(3-4):329-31.
-
Jimbo M, Myers RE, Meyer B, Hyslop T, Cocroft J, Turner BJ, Weinberg DS. Reasons patients with a positive fecal occult blood test result do not undergo complete diagnostic evaluation. Ann Fam Med. 2009 Jan-Feb; 7(1):11-6.
-
Myers RE, Hyslop T, Sifri R, Bittner-Fagan H, Katurakes NC, Cocroft J, Dicarlo M, Wolf T. Tailored navigation in colorectal cancer screening. Med Care. 2008 Sep; 46(9 Suppl 1):S123-31.
-
Myers RE. Patient preferences for colorectal cancer screening. Am J Manag Care. 2007 Nov; 13(11):633-4; author reply 634, 636.
-
Sarfaty M, Wender R. How to increase colorectal cancer screening rates in practice. CA Cancer J Clin. 2007 Nov-Dec; 57(6):354-66.